Gottfried Dölken Selected Research

Gottfried Dölken Research Topics

Disease

10	Lymphoma (Lymphomas) 09/2014 - 06/2003
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2019 - 06/2003
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2021 - 10/2006
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2021 - 05/2007
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2019 - 12/2007
3	Neoplasms (Cancer) 10/2012 - 01/2006
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2012 - 02/2002
3	Infections 12/2011 - 07/2009
2	Thrombocytopenia (Thrombopenia) 01/2013 - 10/2012
2	Hemorrhage 01/2013 - 10/2012
2	Lung Neoplasms (Lung Cancer) 01/2012 - 11/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2013
1	Adenocarcinoma 01/2013
1	Thrombosis (Thrombus) 01/2013
1	Sepsis (Septicemia) 01/2013
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 07/2012
1	Toxoplasmosis 07/2012
1	Necrosis 01/2012
1	Mucositis 01/2011
1	Genetic Translocation (Chromosomal Translocation) 11/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2010
1	Ototoxicity 09/2010
1	Fusariosis 07/2009
1	Plasma Cell Leukemia 04/2007
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 03/2006
1	Invasive Fungal Infections 02/2006
1	Aspergillosis 02/2006
1	Nausea 02/2006
1	Mycoses (Diseases, Fungus) 02/2006
1	Neutropenia 02/2006
1	Hematologic Neoplasms (Hematological Malignancy) 10/2005
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2005
1	Leukemia 10/2005
1	Residual Neoplasm 06/2003

Drug/Important Bio-Agent (IBA)

6	Rituximab (Mabthera)FDA Link 08/2019 - 06/2003
2	AntibodiesIBA 12/2011 - 01/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2008 - 12/2007
2	Chlorambucil (Leukeran)FDA Link 05/2008 - 05/2007
2	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2008 - 05/2007
2	Prednisolone (Predate)FDA LinkGeneric 05/2008 - 05/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2014
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	Alemtuzumab (Campath)FDA Link 07/2013
1	fibrin fragment D (D-dimer)IBA 01/2013
1	Dacarbazine (DIC)FDA LinkGeneric 01/2013
1	Fibrinogen (Factor I)FDA Link 01/2013
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2013
1	MucinsIBA 01/2013
1	Messenger RNA (mRNA)IBA 08/2012
1	Pentamidine (NebuPent)FDA LinkGeneric 07/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	VaccinesIBA 02/2011
1	Immunoglobulin Fab FragmentsIBA 02/2011
1	CreatinineIBA 01/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2010
1	Transcription Factors (Transcription Factor)IBA 11/2010
1	AminoglycosidesIBA 09/2010
1	Methotrexate (Mexate)FDA LinkGeneric 12/2008
1	Proteins (Proteins, Gene)FDA Link 12/2007
1	multidrug resistance-associated protein 1IBA 12/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2007
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2007
1	EnzymesIBA 12/2007
1	Antineoplastic Agents (Antineoplastics)IBA 12/2007
1	Glutathione (Reduced Glutathione)IBA 12/2007
1	InterferonsIBA 05/2007
1	Bortezomib (Velcade)FDA Link 04/2007
1	Indicators and Reagents (Reagents)IBA 10/2006
1	DioxinsIBA 10/2006
1	Fluconazole (Zonal)FDA LinkGeneric 02/2006
1	Itraconazole (Sporanox)FDA LinkGeneric 02/2006
1	SolutionsIBA 02/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2006
1	Monoclonal AntibodiesIBA 06/2003
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2002

Therapy/Procedure

11	Stem Cell Transplantation 06/2021 - 10/2005
11	Therapeutics 08/2019 - 02/2002
10	Drug Therapy (Chemotherapy) 06/2021 - 06/2003
3	Transplantation 10/2012 - 10/2005
2	Immunotherapy 01/2006 - 06/2003
1	Immunomodulation 09/2014
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2012
1	Hematopoietic Stem Cell Transplantation 12/2011
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2006
1	Radioimmunotherapy 10/2005
1	Radiotherapy 06/2003